Once again, and for the 14th consecutive year, the journal Diario Médico has awarded the best ideas of the Spanish Health National System in a celebration that took place in the Teatre Nacional de Catalunya, Barcelona. VHIR was awarded with one of the best ideas in research and pharmacology for the development of a methodology that will help doctors choosing the most efficient treatment for hepatitis C. Doctors Josep Quer, Francisco Rodríguez Frías and Josep Gregori, representing the research group on liver diseases from VHIR and the Service of the Hospital, received the prize, together with Carlos Manchado, from Roche, the pharmaceutical that has been important in this scientific study.This advance, published on February 16, 2015, means the development of a new deep sequencing methodology that accurately classifies the 7 confirmed genotypes of the hepatitis C (HCV) virus, and the different subtypes. The new system also allows, for the first time, to identify infections with more than one subtype of the virus (mixed infections), the variability of the virus and possible resistance mutations."We are going one step further in personalized medicine, because thanks to this new system we can decide which is the treatment with greater chances of success in each patient", reported Dr. Rafael Estaban Mur, head of the Hepatic Diseases group at VHIR and responsible of the Department of Internal Medicine and Hepatology at Vall d'Hebron University Hospital.The two commercial available genotyping methods can only identify the main genotypes and two out of the 67 subtypes of the virus. As the efficacy of new treatments depends on the subtype, physicians do not have tools to choose the most efficient treatment.The study, published in the http://jcm.asm.org/content/53/1/219.long" Journal of Clinical Microbiology, was a collaboration between all the members of the Networked Biomedical Research Center for Hepatic and Digestive Diseases (CIBERehd), Roche and ABL. It is funded with the CDTI MINECO IDI 20110115.Together with VHIR, there was another award for Vall d'Hebron. VHIO was awarded also with one of the best ideas in research and pharmacology for being the first centre of the world to have the liquid biopsy in the study of colorectal cancer.